dr. reddy's labs glp-1 receptor agonists weight management diabetes treatments Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For And Loss Advances in GLP-1 receptor agonists

Expanded uses in inflammatory bowel disease, neurological diseases, and metabolic dysfunction-associated steatohepatitis (MASH)

This case highlights the need for gradual insulin tapering and close monitoring while transitioning from insulin therapy to GIP/GLP-1 receptor agonists.

however, this contradicts established trial data favoring SGLT2 inhibitors for heart failure and should be interpreted cautiously due to possible residual confounding

Consulting the Experts: Prandial Insulin or a GLP-1 Receptor Agonist as Add-On to Basal Insulin

Understand combinations, interactions, and when alternatives may fit better.

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, accelerates cardiometabolic decline and increases mortality risk